keynote-590: pembrolizumab plus chemotherapy for advanced oesophageal cancer
Published 3 years ago • 246 plays • Length 8:45Download video MP4
Download video MP3
Similar videos
-
2:23
pembrolizumab plus chemotherapy for esophageal cancer: keynote-590
-
1:21
dr. shah on the rationale for the keynote-590 trial in esophageal carcinoma
-
7:13
first-line pembrolizumab plus chemotherapy for patients with advanced squamous nsclc: 3-year fol...
-
3:14
keynote-062 study: pembrolizumab as treatment for advanced gastroesophageal junction and gastric...
-
3:44
pembrolizumab plus chemo shows prolonged os and pfs improvement vs chemo for squamous nsclc
-
6:21
pembrolizumab plus trastuzumab and chemotherapy for her2 metastatic gastric or gastroesophageal...
-
2:11
pembrolizumab vs. chemo in first-line mcrc
-
0:37
pembrolizumab shows promise for advanced esophageal cancers
-
1:47
quality of life results from pembrolizumab vs chemotherapy in gastric or gastroesophageal juncti...
-
7:45
pembrolizumab alone or with chemotherapy for advanced gastric/ge junction cancer
-
6:32
latest results from keynote-181: pembrolizumab versus chemotherapy as a second-line therapy for ...
-
8:38
checkmate 459: nivolumab plus chemotherapy for gc / gejc / eac
-
3:13
attraction-3: nivolumab versus chemotherapy in advanced oesophageal squamous cell carcinoma
-
2:44
comment: chemotherapy for frail and elderly patients with advanced gastroesophageal cancer
-
17:28
esophageal cancer with pembrolizumab
-
3:27
towards delivering truly personalised therapy for oesophageal cancer
-
4:54
background of the keynote-158 trial for pembrolizumab in advanced mesothelioma
-
23:25
advances in esophageal cancer: current and future strategies
-
5:14
keynote-859: pembrolizumab plus chemotherapy in g/gej adenocarcinoma